Lisata Therapeutics
LSTA
LSTA
27 hedge funds and large institutions have $10.1M invested in Lisata Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $12.9M → $10.1M (-$2.78M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
27
Holding in Top 10
–
Calls
$2.08M
Puts
$2.18M
Top Buyers
| 1 | +$334K | |
| 2 | +$165K | |
| 3 | +$87.4K | |
| 4 |
Goldman Sachs
New York
|
+$87K |
| 5 |
Millennium Management
New York
|
+$32.9K |
Top Sellers
| 1 | -$936K | |
| 2 | -$175K | |
| 3 | -$139K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$119K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$83K |